Walgreens Boots Alliance (NASDAQ: WBA) reported Q4 EPS of $1.02, $0.06 better than the analyst estimate of $0.96. Revenue for the quarter came in at $34.7 billion versus the consensus estimate of $34.37 billion.

Company Outlook:

The company today introduced fiscal 2021 guidance of low single-digit growth in adjusted earnings per share at constant currency rates.

While the company anticipates a gradual reduction in COVID-19 impacts, the first half results will continue to be negatively impacted when compared with the pre-COVID-19 first half of fiscal 2020. However, for the second half, the company anticipates strong adjusted EPS growth, as these effects subside and recovery plans take hold in key markets.

Significant investments in fiscal 2021 are expected to accelerate the company's customer-centric approach, with specific focus on transforming omnichannel capabilities and offerings across retail and healthcare. These investments are expected to contribute to the second-half growth profile.

While this guidance anticipates a continued gradual reduction in COVID-19 impacts, the evolution of the pandemic remains uncertain. COVID-19 could present both incremental risks as well as opportunities for the company's business.

For earnings history and earnings-related data on Walgreens Boots Alliance (WBA) click here.